Effect of mifepristone on the expression of β-endorphin the ectopic focus of adenomyosis

In: Zhongguo jiceng yiyao · 2011 · vol. 18(09) , pp. 1168–1169 · doi:10.3760/cma.j.issn.1008-6706.2011.09.007 · W3032122809
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-07-17

Mifepristone treatment upregulated β-endorphin expression in adenomyosis ectopic foci, correlating with dysmenorrhea relief.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To investigate the effect of mifepristone on the expression of β-endorphin in the ectopic focus of adenomyosis.Methods The expression of β-endorphin was measured by the immunochemistry method.Results During proliferative phase and secretory phase,the β-endorphin of mild dysmenorrhea were higher than that of midrange dysmenorrhea(t=2.672,2.711,all P<0.05),the β-endorphin of midrange dysmenorrhea was higher than that of severe dysmenorrhea(t=2.341,2.365,all P<0.05),the difference was significant.After being cured by mifepfistone,the expression of β-endorphin in the ectopic focus of adenomyosis was higher than that of control group (t=2.478,2.356,all P<0.05),still lower than that of normal endometrial tissue,(t=2.123,2.233,all P<0.05),the difference was significant.Conclusion The expression of β-endorphin in the ectopic focus of adenomyosis decreased significandy accompanied with the aggravation of the dysmenorrhea,and the mifepfistone could upregulate the β-endorphin and relieve the dysmenorrhea. Key words: Adenomyosis; Dysmenorrhea; β-endorphin; Mifepristone

My notes (saved in your browser only)

Condition tags

adenomyosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK